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A B S T R A C T
Youth with perinatally-acquired HIV (PHIV) experience specific and global cognitive deficits at increased rates
compared to typically-developing HIV-uninfected youth. In youth with PHIV, HIV infects the brain early in
development. Neuroimaging studies have demonstrated altered grey matter morphometry in youth with PHIV
compared to typically-developing youth. This study examined cortical thickness, surface area, and gyrification of
grey matter in youth (age 11–20 years old) with PHIV (n = 40) from the Pediatric HIV/AIDS Cohort Study
(PHACS) compared to typically-developing presumed HIV uninfected and unexposed youth (n = 80) from the
Pediatric Imaging, Neurocognition and Genetics Study (PING) using structural magnetic resonance imaging. This
study also examined the relationship between grey matter morphometry and age. Youth with PHIV had reduced
cortical thickness, surface area, and gyrification compared to typically-developing youth. In addition, an inverse
relationship between age and grey matter volume was found in typically-developing youth, but was not observed
in youth with PHIV. Longitudinal studies are necessary to understand the neurodevelopmental trajectory of
youth with PHIV.
1. Introduction
Perinatal infection with HIV (PHIV) affects the brain early in life.
Selective or global cognitive deficits have been observed in infancy,
childhood and/or adolescence, despite well-controlled disease, and
have implications for mental health, well-being, and successful transi-
tioning to adulthood (Harris et al., 2018; Malee et al., 2016;
Nichols et al., 2016; Smith and Wilkins, 2015). Previous neuroimaging
studies of youth with PHIV have demonstrated differences in grey
matter cortical and subcortical volume, white matter integrity, and
global network connectivity in youth with PHIV compared to typically-
developing youth (Blokhuis et al., 2016; Cohen et al., 2016; Dean et al.,
2020; Herting et al., 2015; Hoare et al., 2018; Lewis-de los Angeles
et al., 2016, Lewis-de los Angeles et al., 2017; Li et al., 2018;
Sarma et al., 2014; Uban et al., 2015). Youth with PHIV may be par-
ticularly vulnerable to structural brain damage given HIV infection
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during early, critical periods of brain development and prolonged ex-
posure to the virus and chronic inflammation intermittently throughout
development (Lewis-de los Angeles et al., 2016).
Normative patterns of structural brain development throughout the
lifespan, particularly cortical grey matter, have previously been char-
acterized by inverted-U curves. Past structural magnetic resonance
imaging (MRI) have shown that cortical grey matter volumes increase
and peak before puberty and then have shown a decrease in grey matter
volume as synapses prune across adolescence into adulthood. Previous
studies have differed on when this peak occurs (i.e., childhood vs.
adolescence), with most findings showing widespread cortical thinning
with increasing age during adolescence (Tamnes et al., 2017). More-
over, these normative patterns of development are heterogeneous by
anatomic regions, grey matter metrics, individual subject character-
istics, and different trajectories among disorders of neurodevelopment
(Astley et al., 2009; Giedd and Rapoport, 2010; Walhovd et al., 2016).
To date, few neuroimaging studies have focused on how HIV alters
brain structure at different ages (Van den Hof et al., 2019). In adult
males with HIV, brain structure trajectories exhibited more atrophy in
the absence of, compared to those with continued, cART medication
(Sanford et al., 2018). However, how trajectories differ during key
developmental time periods with HIV infection and with or without
medication requires future investigation.
Various cortical grey matter components, such as surface area,
cortical thickness, and gyrification, can be differentially affected in
neurodevelopment of youth with PHIV. These grey matter metrics
overlap in their changes over time, but also offer unique variance and
are thought to relate to different biological factors (Storsve et al., 2014)
with different rates of maturation (Raznahan et al., 2011). Previous
studies have examined the relationships between these measures of
cortical morphometry and PHIV in pre-defined regions-of-interest of the
brain (Nwosu et al., 2018). This study adds vertex-level analysis of grey
matter anatomical differences of the brain, not limited to predefined
regions of interest. The current study examined the relationships be-
tween specific morphometric measures of grey matter and PHIV, as well
as the relationship between age and grey matter volume on the cortical
surface in a cross-sectional sample of youth with PHIV. We hypothe-
sized that youth with PHIV would have reduced grey matter measures
(surface area, cortical thickness, and local gyrification) both globally
and regionally compared to typically-developing youth.
2. Methods
2.1. Study population
We evaluated a cohort of 40 youth (age 11–20 years) with PHIV
enrolled at a single site in 2007–2009 (the Ann and Robert H. Lurie
Children's Hospital of Chicago) of the Adolescent Master Protocol
(AMP) study, conducted by the Pediatric HIV/AIDS Cohort Study
(PHACS) network (https://phacsstudy.org/), who underwent multi-
modal MRI acquisition. In general, the PHACS AMP study is a long-
itudinal cohort study aimed at investigating long-term effects of HIV
infection and antiretroviral therapy among youth with PHIV. This
particular cohort of 40 youth with PHIV has previously been described
(Herting et al., 2015; Lewis-de los Angeles et al., 2016, Lewis-de los
Angeles et al., 2017; Uban et al., 2015). Institutional review boards
(IRB) at the participating site and the Harvard T. H. Chan School of
Public Health approved the study. Parents, legal guardians, and youth
with PHIV who were 18 years or older provided written informed
consent for research participation; participating minor adolescents
provided assent.
As a comparison group with harmonized MRI acquisition protocols,
we selected a subset of 80 youth, presumed HIV-unexposed and unin-
fected, from the Pediatric, Imaging, Neurocognition, and Genetics
(PING) study. The selection was made to 2:1 ratio of number of PING
and PHACS participants, with group matching for age, race, ethnicity,
caregiver education, and household income. For patients with missing
data, multiple imputation was performed. Study population demo-
graphic, clinical, cognitive, and substance use data as well as imaging
data were obtained through the PING portal after execution of data use
requests and agreement to data use policies (Brown et al., 2012). We
note that neuroimaging data in PING and PHACS were collected ac-
cording to the same protocol.
2.2. Image acquisition and processing
All MRIs of the brains were collected on 3.0 Tesla Siemens
Magnetom Tim Trio Scanner as described in previous studies
(Herting et al., 2015; Lewis-de los Angeles et al., 2016, Lewis-de los
Angeles et al., 2017; Uban et al., 2015). Structural MRIs were con-
ducted using a T1-weighted, MP-RAGE sequence (sagittal, TR/TE/
TI = 2,170/4.37/1,100 ms, FOV = 256 × 256 mm, flip angle = 7o,
voxel resolution = 1 × 1 × 1.2 mm3, scan time = 8:08). No sedation
was used for participants in either study. All selected subjects from the
PING study and the PHACS study were scanned on 3T Siemens scanners
using the same imaging protocol, except for 8 channel head coil used in
the control youth and a 12 channel head coil in youth with PHIV. As in
previous studies, PHACS structural MRI data were analyzed using the
same processing pipeline as the PING participants (Herting et al., 2015;
Lewis-de los Angeles et al., 2016, Lewis-de los Angeles et al., 2017;
Uban et al., 2015). Specifically, scans were analyzed using FreeSurfer
5.3.0 (processed on CentOS 6 × 86_64) to generate cortical surfaces
(see http://surfer.nmr.mgh.harvard.edu/). The automated process in-
volved motion correction, intensity normalization, Talairach transfor-
mation, segmentation of grey and white matter volumes, tessellation of
boundaries, topology correction, and surface deformation to generate
cortical surfaces. Inflated surfaces registered to spherical atlases al-
lowed for analyses of surface morphometry, including cortical thick-
ness, surface area, and local gyrification index (Dale et al., 1999;
Desikan et al., 2006; Fischl et al., 2002, 2004; Fischl and Dale, 2000;
Schaer et al., 2012). Quality assurance procedures were carried out
according to FreeSurfer recommended protocols. SurfStat was used to
perform exploratory vertex-wise analyzes on the surface (see http://
www.math.mcgill.ca/keith/surfstat/) (Chung et al., 2010;
Worsley et al., 2009).
2.3. Statistical analyses
Demographic characteristics of PHIV and control youth were sum-
marized and compared using Fisher's exact tests for binary measures,
Chi-Square tests for categorical variables, and Wilcoxon rank sum test
for continuous measures. Spatial distribution vertex-wise analyses were
performed to identify vertices (points on the cortical surface of the
brain) and clusters (statistically significant spatially-contiguous re-
gions) that were associated with morphometric differences between
PHIV youth and control youth (from the PING sample). Mean cortical
volume at each vertex over the whole brain was compared in youth
with PHIV and control youth. Multivariate (multiple) linear regression
was used to obtain clusters of significant (p < 0.05) relationships be-
tween grey matter metrics on cortical surfaces (volume, surface area,
cortical thickness, and local gyrification index) (Dale et al., 1999;
Desikan et al., 2006; Schaer et al., 2012) and group (PHIV vs. control
youth). Multiple comparisons were corrected with random field theory
(RFT) (Chung et al., 2010); vertices that survived cluster-level correc-
tion using familywise error rate (FWER) <0.05 were identified as sig-
nificant on the surface using SurfStat (Worsley et al., 2009). Models for
each grey matter metric were used to test for group effect (PHIV vs.
controls), adjusting for age at imaging (continuous) and sex. In this
cross-sectional design, we evaluated the relationship of age with each
grey matter metric (area, thickness, gyrification) by fitting a separate
model within each of the groups (PHIV and control youth) for each
metric as a function of age, adjusting for sex. For the analyses relating
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age to grey matter metric, two models were used. First, within-group
analyses of grey matter metric (volume, cortical thickness, surface area,
local gyrification) at each vertex was related to age, adjusting for sex.
Second, as an exploratory analysis, scatter plots for both control youth
and youth with PHIV were generated depicting age-grey matter volume
relationships in regions identified significantly related to age in the
control youth. Linear regression was performed. We fit a second model
to explore a group by age interaction.
3. Results
3.1. Study population
Characteristics for the 40 youth with PHIV and 80 typically-devel-
oping youth are shown in Table 1; as a result of group matching,
distributions with respect to age, race, ethnicity, caregiver education,
and household income were very similar. However, the female parti-
cipants tended to be younger within the PHIV group than in the control
youth (mean age (years) = 15.9 vs 17.1 years, respectively, p = 0.07)
while the males tended to be older within the PHIV group than in
control youth (mean age (years) = 17.6 vs 15.7 years, respectively,
p = 0.005).
3.2. Comparison of grey matter metrics between PHIV youth and control
youth
Mean cortical volume for each vertex across the whole brain was
significantly different in youth with PHIV compared to control youth
(youth with PHIV: 1.41, control youth 1.53, t(118) =−3.55, p< 001).
Compared to control youth, youth with PHIV exhibited cortical thin-
ning that appeared limited in terms of both degree and range in ana-
tomical locations overall: thinning appeared largely concentrated on
the right hemisphere. Between-group analyses revealed that youth with
PHIV had smaller cortical thickness than control youth in regions of the
right and left primary motor areas, right superior frontal, left inferior
parietal cortices, left posterior temporal, and right temporal lobes
(Fig. 1).
In youth with PHIV, reduced surface area was found bilaterally,
with most reductions in the lateral superior and temporal lobe bilat-
erally, as well as left medial temporal lobe and right cingulate cortex
(Fig. 2).
Youth with PHIV exhibited significantly reduced local gyrification
index, primarily in the left hemisphere. Specifically, youth with PHIV
had lower gyrification than control youth in regions of the left lateral
and medial frontal lobes, the left and right temporal lobes, and the right
lateral parietal cortex and temporal lobe (Fig. 3).
3.3. Relationship between grey matter metrics correlation and age: within-
group analyses
In the control youth, distributed symmetric clusters in the left and
right hemispheres, largely in the frontal cortex, showed negative as-
sociation between age and grey matter volume. There were also addi-
tional clusters of negative associations between age and grey matter
volume in the medial and lateral temporal lobe, though these clusters
were smaller than those in the frontal lobe. In PHIV youth, there were
no statistically significant relationships between age and grey matter
volume (Fig. 4). We did not observe any regions of the brain that had
significant interaction between age and group, though the study may
have been underpowered to detect such an effect. Similar results were
found for cortical thickness, surface area, and local gyrification index
(Supplemental Fig. 2). There were significant associations between age
and grey matter metric (cortical thickness and gyrification) in dis-
tributed regions in bilateral frontal, parietal, and temporal lobe in the
control youth, but not in youth with PHIV. For surface area, there were
clusters in the left medial temporal lobe and right occipital lobe asso-
ciated with age in the control youth, but not in youth with PHIV. Linear
regression for age related to volume in regions identified significantly
related to age in the control youth were performed. In youth with PHIV,
there was no significant relationship (r = −0.1359, p = 4066.). In
control youth, there was a significant relationship between age and
volume (r = −0.5332, p < 001.)
4. Discussion
Using vertex-level analysis, we identified surface clusters of reduced
grey matter thickness, surface area, and gyrification index in youth with
PHIV compared to typically-developing youth in distributed regions
throughout the cortex, including the frontal and parietal regions iden-
tified in previous studies of grey matter volume, but also in the tem-
poral lobe of youth in the age range of 11–20 years old (Cohen et al.,
Table 1
Characteristics of study population by group
PHIV (n = 40) PING
(n = 80)
p-value
Female (n(%)) 21 (53%) 40 (50%) 0.80
Age (mean (SD)) 16.7 (2.4) 16.3 (2.8) 0.66
Race (n(%)) 0.44
Black 29 (73%) 52 (65%)
White 10 (25%) 28 (35%)
Hispanic ethnicity (n(%)) 5 (13%) 10 (13%) 1.00
Caretaker education (n(%))a 0.35
Less than high school 7 (18%) 8 (10%)
High School or GED 13 (33%) 28 (35%)
Some college or 2 year degree 10 (25%) 25 (31%)
4 year college 3 (7.5%) 12 (15%)
Graduate School 7 (18%) 7 (8.8%)
Annual household income (n(%))b 0.52
Less than 10000 2 (5%) 5(6.3%)
10001–20000 10 (25%) 11 (14%)
20001–30000 6 (15%) 14 (18%)
30001–40000 6 (15%) 14 (18%)
40001–50000 3 (7.5%) 3 (3.8%)
50001–100000 11 (28%) 21 (26%)
greater than 100000 2 (5%) 12 (15%)
HIV disease-severity measures (median (Q1, Q3) or N (%) for PHIV
CD4% < 15% 17 (43%)
Nadir CD4% 16.5 (8.0,23.8)
Age (years) at nadir CD4% 5.7 (2.2,10.9)
Nadir CD4 count 236.0 (112.0,
392.5)
Age (years) at nadir CD4 count 8.2 (3.8, 11.6)
Most recent* CD4 count 627 (453.0,
846.0)
Most recent* CD4% 35.9 (27.6,42.9)
Age (years) at most recent
CD4%/CD4 count
17.0 (14.9,18.2)
Log peak HIV RNA viral load
(copies/mL)
5.7 (5.2,5.9)
Age (years) at peak RNA 2.5 (0.6,5.3)
Most recent* RNA count > 400
copies/mL
6 (15)
Age (years) at most recent RNA 17.0 (14.9, 18.2)
% of viral load > 1000 copies/
mL in past 5 years
6.5 (0.0, 29.0)
Age at start of cART 3.5 (1.4 -6.3)
ARV regimen at the time of scan
cART 37(92%)
Not on cART 1 (3%)
Not on any antiretrovirals 2 (5%)
CDC ‘C’ Classification 9 (22%)
GED = General Education Development test passed.
Cart = combination antiretrovial therapy (regimen including at least 3 drugs
from at least 2 drug classes).
CDC = Centers for Disease Control.
⁎ Most recent = closest clinical data to neuroimaging scan.
a One missing value of PING subjects imputed.
b Eleven missing values of PING subjects imputed.
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2016; Lewis-de los Angeles et al., 2017). These findings occurred in the
setting of mean cortical volume reduction over the whole brain in youth
with PHIV compared to control youth. This confirms our hypothesis
that multiple cortical grey matter morphometric measures (i.e., cortical
thickness, surface area, and gyrification index) are vulnerable to HIV
infection. This pattern is supported by earlier studies (Cohen et al.,
2016), and the present study adds to earlier grey matter studies of this
sample of youth with PHIV enrolled in the PHACS study (Lewis-de los
Angeles et al., 2016, Lewis-de los Angeles et al., 2017) . These findings
of smaller grey matter volumes, reduced cortical surface area and
Fig. 1. Youth with PHIV(n = 40) had smaller
cortical thickness than control youth (n = 80).
Surface clusters (purple) indicate significantly
smaller cortical thickness in PHIV than control
youth with adjustment for age and sex (RFT-
FWER, p < 0.05). Cooler colors indicate youth
with PHIV had smaller cortical thickness than
controls. Warmer colors would be indicative of
a thicker cortex in PHIV compared to controls,
although no such findings were observed. Scale
bar indicates range of standardized regression
coefficients. (For interpretation of the refer-
ences to color in this figure legend, the reader
is referred to the web version of this article.)
Fig. 2. Youth with PHIV (n = 40) had smaller
surface area than control youth (n = 80).
Surface clusters (purple) indicate significantly
smaller surface area in PHIV than control
youth with adjustment for age and sex (RFT-
FWER, p < 0.05). Cooler colors indicate youth
with PHIV had smaller surface area than con-
trols. Warmer colors would be indicative of a
larger surface area in PHIV compared to con-
trols, although no such findings were observed.
Scale bar indicates range of standardized re-
gression coefficients. (For interpretation of the
references to color in this figure legend, the
reader is referred to the web version of this
article.)
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decreased gyrification index have also been identified in a younger
cohort 9–11-year old children with PHIV (Hoare et al., 2018). Further, a
recent study comparing volume, cortical thickness, and surface area
between HIV- infected youth and HIV-exposed uninfected found subtle
differences between the two groups, suggesting both in utero and
postnatal effects of the virus (Dean et al., 2020). Interestingly,
Dean et al., (2020) identify reductions in surface area in the right
temporal lobe as well as cortical thickness in the left frontal lobe, but
not in other regions when comparing HIV-infected and HIV-exposed
uninfected youth. These regions may be particularly vulnerable to HIV,
while other regions found to be altered in the present study but not in
Dean et al., (2020) may relate more to timing of successful viral
suppression, which differs between the studied populations.
A recently published systematic review highlighted that previous
studies of structural magnetic resonance imaging have identified both
similar and different grey matter regions affected across studies, which
is also true in our findings (Van den Hof et al., 2019). It is unclear why
both different and similar regions or lateralization of findings have been
identified in these neuroimaging studies. One potential explanation
could be differential microglia concentration. In particular, animal
studies have shown that in general, microglia have different con-
centrations in different regions of the brain (Lawson et al., 1990;
Tan et al., 2020). As microglia are a major reservoir of HIV in the
central nervous system, one possibility is that this differential brain
Fig. 3. Youth with PHIV (n = 40) had lower
gyrification index than control youth (n= 80).
Surface clusters (purple) indicate significantly
lower gyrification index in PHIV than control
youth with adjustment for age and sex (RFT-
FWER, p < 0.05). Cooler colors indicate youth
with PHIV had lower gyrification index than
control youth. Warmer colors would indicate
youth with PHIV had larger gyrification index
than controls, although no such findings were
observed. Scale bar indicates range of stan-
dardized regression coefficients. (For inter-
pretation of the references to color in this
figure legend, the reader is referred to the web
version of this article.)
Fig. 4. Youth with PHIV (n= 40) did not show
age-related volume reduction typically seen in
control youth (n = 80). Clusters indicate sig-
nificant relationship between age and volume
within PHIV and control youth with adjust-
ment for sex. Cooler colors indicate negative
association between volume and age (RFT-
FWER, p < 0.05). Warmer colors would in-
dicate there is a positive association between
volume and age, though no such relationships
were observed. Scales indicates ranges of
coefficient of association for the magnitude of
the volume-age relationships.
C.P. Lewis-de los Angeles, et al. NeuroImage: Clinical 26 (2020) 102246
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geographic concentration of microglia contributes to the observed grey
matter differences observed in youth with HIV. Another potential
reason that different regions have been identified from prior neuroi-
maging studies may be due to differences in comparison samples, for
example comparing to typically-developing youth versus comparing to
HIV-exposed uninfected, or comparing samples with slightly different
age groups, geographic locations, or timing of viral suppression. Al-
ternatively, other methodological differences such as in the analysis
technique may be responsible for heterogenous findings.
Generally, reductions in surface area and gyrification in youth with
PHIV were found in the frontal lobe, whereas the extent of frontal lobe
differences in cortical thickness measures was much smaller. The pat-
tern of changes in grey matter components identified in this study may
reflect how PHIV most significantly affects neurodevelopment.
Examining individual components such as cortical thickness (possibly
reflecting changes in neuronal size, number of spines and synapses) and
surface area (possibly reflecting cortical column generation)
(Klein et al., 2014; Raznahan et al., 2011; Storsve et al., 2014), is
helpful to more fully understand specific deficits and neurological in-
sults of PHIV across the duration of brain development. In addition,
gyrification reflects radial expansion of cortex and can be especially
sensitive to early defects of cortical development (Klein et al., 2014;
Schaer et al., 2012). The current understanding of gyrification is that
cortical folds appear while in utero and gyrification increases through
early childhood, stabilizes, then decreases in adolescence until early
adulthood (Klein et al., 2014; Schaer et al., 2012). The pattern of re-
ductions in gyrification and surface area, but not thickness, may be
partially explained by the observation that by the second year of life,
cortical thickness has achieved 97% of adult values, compared with a
total surface area of only 69% of expected young adult size (Lyall et al.,
2015), leading to continued surface area development throughout the
first two decades of life. Thus, youth with PHIV may have more sig-
nificant continued effects on cortical column generation and radial
expansion of the cortex, and thus surface area and gyrification, re-
spectively, in the frontal lobe beyond this period, rather than neuronal
properties (cell size, arborization, spines) as reflected by lack of changes
in cortical thickness.
Whether youth with PHIV have similar rates of decline or altered
thinning in this age group compared to typically-developing youth is
not yet known. Disorders of neurodevelopment, such as attention-def-
icit hyperactivity disorder, schizophrenia, and fetal alcohol syndrome
have demonstrated distinct and varied trajectories of grey matter de-
velopment (Astley et al., 2009; Giedd & Rapoport, 2010). It is possible
that, similarly to these neurodevelopmental disorders, greater benefits
may be observed with earlier induction of interventions for individuals
with PHIV in terms of determining trajectory of brain development
(Giedd and Rapoport, 2010; Castellanos et al., 2002). This cross-sec-
tional study of the relationship of age with grey matter volume suggests
that typically-developing youth demonstrate linear cortical volume
reduction in this age range, thought to be a sign of effective maturation
and pruning, whereas youth with PHIV may not undergo this matura-
tion process in adolescence. This study may suggest that youth with
PHIV have reduced grey matter cortical thickness and surface area to
begin with, but do not undergo effective synaptic maturation. Other
studies of blood markers of epigenetic aging suggest that youth with
PHIV may have accelerated aging (Horvath et al., 2018); however, how
this correlates with grey matter morphometry is not yet understood.
The interpretations of these analyses must be understood in the
context of their limitations. Given the limited sample size of the HIV-
infected group, it is likely that we did not have sufficient power to
detect group interactions on the association with age. Moreover, the
non-linear inverted U shape relationship between cortical gray matter
and age shown by previous larger studies spanned wider age ranges (for
one study, the age range was 3–20 years (Brown et al., 2012), for an-
other study, 4–22 years (Giedd et al., 1999)). For these studies, grey
matter appeared to peak in later childhood, 10–12 years. The smaller,
older age range of our study (11–20 years) may have prevented us from
testing the non-linear hypothesis. In our study, analyses examining
relationships between age and grey matter metrics made a simplifying
assumption of linearity in age, which appeared to be satisfied within the
typically-developing youth group. However, given the limited size of
the HIV-infected group it is unclear whether we had too little power to
detect associations with age, or whether the relationship with age was
potentially non-linear and thereby obscured overall trends with age.
Possible non-linear relationships may have also impacted our tests for
interaction between age and HIV status. Larger future studies should
study adolescents across a wide range of ages to more fully understand
the complex relationships with age in this population.
Further, given our smaller sample size, it is not yet clear if HIV
affects males and females differently. It should also be noted that sex is
one of the strongest predictors of brain size, especially in the adolescent
age range (Giedd and Rapoport, 2010). Since males and females enter
puberty at different ages, and synaptic pruning and the characteristic
downward slope of the inverted-U grey matter occurs after the start of
puberty (Giedd, 2004; Giedd and Rapoport, 2010), it is possible that
males and females experience the interacting effects of HIV and brain
volume changes differently.
Another limitation of our study is healthy volunteer bias. It is pos-
sible that the individuals who volunteer to participate in studies, in-
cluding neuroimaging studies, may represent a healthier and wealthier
sample of the general population (Ganguli et al., 2015; Oswald et al.,
2013). Socioeconomic status has been shown to affect brain volumes in
prior structural magnetic resonance imaging studies (Brito and Noble,
2014; Lawson et al., 2013; Noble et al., 2012, 2015). To minimize the
effect of socioeconomic status, the present study matched the samples
utilizing grouped ranges for two SES factors (annual household incomes
and caregiver education). Despite these efforts, there were residual
sociodemographic differences, with a higher frequency of participants
with PHIV towards the lower end of the lowest income range compared
to controls. Likewise, there were more control youth towards the high
end of highest income range compared to youth with PHIV
Finally, this was a cross-sectional study of the relationship of age
with cortical grey matter, providing a snapshot of possible longitudinal
relationships. One study that examined subcortical abnormalities
longitudinally observed shape differences in youth with PHIV at the
initial evaluation, and the differences diminished over a year (Wade
et al., 2019). This suggests that longitudinal differences may be minor
when examining an endpoint; however, diminished changes at one year
could also reflect an altered neurodevelopmental trajectory. Future
studies should evaluate the correlations of these structural abnormal-
ities with cognitive and behavioral outcomes. In order to further
characterize the neurodevelopmental trajectories of youth with PHIV,
larger longitudinal neuroimaging studies with multiple timepoints
across the lifespan are warranted.
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